by Patrick R. Coyle | Sep 11, 2026 | Launch and Commercialization
Half of a launch class misses its first-year forecast. The post-mortems almost always blame the forecast. In my experience the forecast was close to right about the patients. It was wrong about how many of them would make it all the way to a paid dispense. New product...
by Patrick R. Coyle | Sep 1, 2026 | Launch and Commercialization
A first commercial launch with nothing to inherit, and the governance decision that mattered more than any design choice. Directing commercialization infrastructure for an emerging biotech, I built the roadmap to revenue, paired third-party logistics with specialty...
by Patrick R. Coyle | Sep 1, 2026 | Launch and Commercialization
What changes at approval is not the product and not the patient. It is who is looking at them, and what they are counted for. Supporting a program from R&D finance through launch, I carried the clinical understanding of the patient into the commercial models,...
